Drugmaker Abbott India posts Q4 profit rise on higher sales
BENGALURU (Reuters) - Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales...
16h ago
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
(Reuters) - Drugmaker Viatris narrowly missed first-quarter revenue estimates on Thursday, hurt by weak sales for its older d...
16h ago
Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies
(Reuters) - Metaphore Biotechnologies said on Thursday it would collaborate with Novo Nordisk to develop up to two therapies ...
17h ago
Merck treatment for a type of uterus cancer fails trial
(Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the main goal of disease-free survi...
18h ago
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
TOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as the company focused on r...
23h ago
UK refuses to sign global vaccine treaty, The Telegraph reports
(Reuters) - Britain is refusing to sign the World Health Organization's pandemic accord because the country says it would hav...
May 08, 2024
Ascension warns of suspected cyberattack; clinical operations disrupted
(Reuters) - Hospital operator Ascension reported disruptions to its clinical operations on Wednesday due to a suspected cyber...
May 08, 2024
US FDA recommends healthcare providers switch from Getinge's heart devices
(Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Ge...
May 08, 2024
Google DeepMind unveils next generation of drug discovery AI model
By Martin Coulter LONDON (Reuters) - Google Deepmind has unveiled the third major version of its "AlphaFold" artifi...
May 08, 2024
Teva Pharm Q1 profit misses estimates, revenue risea
By Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter ...
May 08, 2024